Literature DB >> 10922382

RET genotypes comprising specific haplotypes of polymorphic variants predispose to isolated Hirschsprung disease.

S Borrego1, A Ruiz, M E Saez, O Gimm, X Gao, M López-Alonso, A Hernández, F A Wright, G Antiñolo, C Eng.   

Abstract

BACKGROUND: Hirschsprung disease (HSCR), which may be sporadic or familial, occurs in 1:5000 live births and presents with functional intestinal obstruction secondary to aganglionosis of the hindgut. Germline mutations of the RET proto-oncogene are believed to account for up to 50% of familial cases and up to 30% of isolated cases in most series. However, these series are highly selected for the most obvious and severe cases and large familial aggregations. Population based studies indicate that germline RET mutations account for no more than 3% of isolated HSCR cases. Recently, we and others have noted that specific polymorphic sequence variants, notably A45A (exon 2), are over-represented in isolated HSCR.
PURPOSE: In order to determine if it is the variant per se, a combination thereof, or another locus in linkage disequilibrium which predisposes to HSCR, we looked for association of RET haplotype(s) and disease in HSCR cases compared to region matched controls.
METHODS: Seven loci across RET were typed and haplotypes formed for HSCR cases, their unaffected parents, and region matched controls. Haplotype and genotype frequencies and distributions were compared among these groups using the transmission disequilibrium test and standard case-control statistic.
RESULTS: Twelve unique haplotypes, labelled A-L, were obtained. The distributions of haplotypes between cases and controls (chi(11)(2) =81.4, p<<0.0001) and between cases and non-transmitted parental haplotypes were significantly different (chi(2)(11)=53.1, p<0.0001). Genotypes comprising pairs of haplotypes were formed for cases and controls. There were 38 different genotypes among cases and controls combined. Inspection of the genotypes in these two groups showed that the genotype distribution between cases and controls was distinct (chi(37)(2)=93. 8, p<<0.0001). For example, BB, BC, BD, and CD, all of which contain at least one allele with the polymorphic A45A, are prominently represented among HSCR cases, together accounting for >35% of the case genotypes, yet these four genotypes were not represented among the population matched normal controls. Conversely, AA, AG, DD, GG, and GJ, none of which contains A45A, are commonly represented in the controls, together accounting for 43% of the control genotypes, and yet they are never seen among the HSCR cases.
CONCLUSIONS: Our data suggest that genotypes comprising specific pairs of RET haplotypes are associated with predisposition to HSCR either in a simple autosomal recessive manner or in an additive, dose dependent fashion.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10922382      PMCID: PMC1734658          DOI: 10.1136/jmg.37.8.572

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  37 in total

1.  Specific polymorphisms in the RET proto-oncogene are over-represented in patients with Hirschsprung disease and may represent loci modifying phenotypic expression.

Authors:  S Borrego; M E Sáez; A Ruiz; O Gimm; M López-Alonso; G Antiñolo; C Eng
Journal:  J Med Genet       Date:  1999-10       Impact factor: 6.318

2.  A human model for multigenic inheritance: phenotypic expression in Hirschsprung disease requires both the RET gene and a new 9q31 locus.

Authors:  S Bolk; A Pelet; R M Hofstra; M Angrist; R Salomon; D Croaker; C H Buys; S Lyonnet; A Chakravarti
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

3.  A genetic study of Hirschsprung disease.

Authors:  J A Badner; W K Sieber; K L Garver; A Chakravarti
Journal:  Am J Hum Genet       Date:  1990-03       Impact factor: 11.025

4.  The genetics of Hirschsprung's disease. Evidence for heterogeneous etiology and a study of sixty-three families.

Authors:  E Passarge
Journal:  N Engl J Med       Date:  1967-01-19       Impact factor: 91.245

5.  The ret proto-oncogene is consistently expressed in human pheochromocytomas and thyroid medullary carcinomas.

Authors:  M Santoro; R Rosati; M Grieco; M T Berlingieri; G L D'Amato; V de Franciscis; A Fusco
Journal:  Oncogene       Date:  1990-10       Impact factor: 9.867

6.  A gene for Hirschsprung disease maps to the proximal long arm of chromosome 10.

Authors:  S Lyonnet; A Bolino; A Pelet; L Abel; C Nihoul-Fékété; M L Briard; V Mok-Siu; H Kaariainen; G Martucciello; M Lerone; A Puliti; Y Luo; J Weissenbach; M Devoto; A Munnich; G Romeo
Journal:  Nat Genet       Date:  1993-08       Impact factor: 38.330

7.  Haplotype relative risks: an easy reliable way to construct a proper control sample for risk calculations.

Authors:  C T Falk; P Rubinstein
Journal:  Ann Hum Genet       Date:  1987-07       Impact factor: 1.670

8.  Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM).

Authors:  R S Spielman; R E McGinnis; W J Ewens
Journal:  Am J Hum Genet       Date:  1993-03       Impact factor: 11.025

9.  Mutations of the RET proto-oncogene in Hirschsprung's disease.

Authors:  P Edery; S Lyonnet; L M Mulligan; A Pelet; E Dow; L Abel; S Holder; C Nihoul-Fékété; B A Ponder; A Munnich
Journal:  Nature       Date:  1994-01-27       Impact factor: 49.962

10.  Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease.

Authors:  G Romeo; P Ronchetto; Y Luo; V Barone; M Seri; I Ceccherini; B Pasini; R Bocciardi; M Lerone; H Kääriäinen
Journal:  Nature       Date:  1994-01-27       Impact factor: 49.962

View more
  25 in total

Review 1.  Hirschsprung disease, associated syndromes, and genetics: a review.

Authors:  J Amiel; S Lyonnet
Journal:  J Med Genet       Date:  2001-11       Impact factor: 6.318

2.  A founding locus within the RET proto-oncogene may account for a large proportion of apparently sporadic Hirschsprung disease and a subset of cases of sporadic medullary thyroid carcinoma.

Authors:  Salud Borrego; Fred A Wright; Raquel M Fernández; Nita Williams; Manuel López-Alonso; Ramana Davuluri; Guillermo Antiñolo; Charis Eng
Journal:  Am J Hum Genet       Date:  2002-12-09       Impact factor: 11.025

3.  Novel sequence variants of the genes associated with the multiple endocrine neoplasia syndromes 1 and 2. analysis by an "in silico approach.".

Authors:  P Igaz; A Patócs; K Rácz
Journal:  J Endocrinol Invest       Date:  2002 Jul-Aug       Impact factor: 4.256

4.  Single nucleotide polymorphisms in the RET gene and their correlations with Hirschsprung disease phenotype.

Authors:  Robert Smigiel; Arleta Lebioda; Dariusz Patkowski; Jerzy Czernik; Tadeusz Dobosz; Karolina Pesz; Monika Kaczmarz; Maria M Sasiadek
Journal:  J Appl Genet       Date:  2006       Impact factor: 3.240

5.  An entropy-based genome-wide transmission/disequilibrium test.

Authors:  Jinying Zhao; Eric Boerwinkle; Momiao Xiong
Journal:  Hum Genet       Date:  2007-02-13       Impact factor: 4.132

Review 6.  Genetic basis of Hirschsprung's disease.

Authors:  Paul K H Tam; Mercè Garcia-Barceló
Journal:  Pediatr Surg Int       Date:  2009-06-12       Impact factor: 1.827

Review 7.  Genetic modifiers and oligogenic inheritance.

Authors:  Maria Kousi; Nicholas Katsanis
Journal:  Cold Spring Harb Perspect Med       Date:  2015-06-01       Impact factor: 6.915

8.  Low RET mutation frequency and polymorphism analysis of the RET and EDNRB genes in patients with Hirschsprung disease in Taiwan.

Authors:  Trang-Tiau Wu; Tsui-Wei Tsai; Chao-Ta Chu; Zen-Fung Lee; Chuan-Mao Hung; Ching-Chyuan Su; Shuan-Yow Li; Mingli Hsieh; Chuan Li
Journal:  J Hum Genet       Date:  2005-04-15       Impact factor: 3.172

9.  Mutation of RET gene in Chinese patients with Hirschsprung's disease.

Authors:  Ji-Cheng Li; Shi-Ping Ding; Ying Song; Min-Ju Li
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

Review 10.  Chromosomal and related Mendelian syndromes associated with Hirschsprung's disease.

Authors:  S W Moore
Journal:  Pediatr Surg Int       Date:  2012-09-23       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.